Addiction and Menopause: The Hidden Cycle of Self-Medication in Midlife
Medically reviewed by Paul Hornsey
Menopause and perimenopause can come with a range of psychological and physiological challenges that are often unexpected and may linger for years1. As hormonal changes occur, women find themselves navigating mood swings and experiencing increased anxiety and cognitive changes2. Physiologically, symptoms of perimenopause and menopause include weight gain, fatigue, night sweats and sleep issues3.
For individuals in C-suite environments, the profound changes that occur during these stages of a woman’s life can increase vulnerability to self-medicating behaviours to recalibrate mood, revitalise energy, and regulate sleep patterns4-5. Seemingly soothing and innocuous at first – a glass of wine in the evening after a busy day, or a sleeping pill to ensure sufficient rest before an important pitch – such behaviours can evolve into dependency when used to manage chronic stress or hormonal symptoms6-8. This, in turn, can affect relationships, careers, and overall outlook on life9.
According to a recent study published in the British Journal of Education, Learning and Development Psychology, addiction and menopause go hand in hand: 65% of menopausal women use alcohol and 30% use sedatives to address anxiety, depression and sleep disturbances10-11. Particularly vulnerable are women with a history of trauma, abuse or mental health conditions10-11.
The complex matter of substance dependencies that may arise in midlife calls for a carefully tailored, multifaceted approach that ensures lasting health and wellness – and leading professionals that place equal importance on physical and mental health, viewing every challenge through the prism of each individual.
The Effect of Hormones and Neurochemistry on Mood, Sleep and Productivity
While the perimenopausal years are characterised by fluctuations in the level of oestrogen and progesterone, menopause is broadly defined by the decrease of the two hormones12-14.
Chemically, oestrogen contributes to mood stability and cognitive clarity – enhancing serotonin and dopamine activity in the brain15-16. As such, declining oestrogen levels have been linked in studies to mood dysregulation, reduced motivation, and heightened vulnerability to depression and anxiety3,17.
According to a meta-analysis published in the Journal of Affective Disorders, during perimenopause mental health challenges may worsen, with the risk of depression being the highest18.
According to a meta-analysis published in the Journal of Affective Disorders, during perimenopause mental health challenges may worsen, with the risk of depression being the highest18.
Similarly, with fluctuating and falling levels of progesterone – a hormone responsible for sleep patterns and the feeling of calm regulated by the GABA neurotransmitter – women may experience restlessness and irritability, on top of disrupted sleep patterns19.
The effect for women that lead fast-paced lives can be profound. A change in sleep alone can lead to increased anxiety and restlessness19-20. Coupled with diminished cognitive performance and possible irritability, women who find themselves in this position may make the decision to self-medicate.
The boundary between healthy coping mechanisms and self-medication can blur. It is not uncommon for women navigating the hormonal variability of perimenopause and the enduring changes of menopause to turn to alcohol, sedatives or stimulants21-23.
Long-term use of stimulants increase energy briefly but result in a plunge; alcohol disrupts sleep and leads to increased tiredness24-25; sedatives increase the tolerance and create dependency26-28. Worse, these attempts to solve the short-term issue may even become unrecognised dependencies. Individuals with substance use challenges often carry the burden of the implications of sharing their secret29-32.
The Invisibility of Addiction and Menopause in Midlife
Outside of the proverbial hot flashes referenced in the mass media, perimenopause and menopause are rarely the subject of meaningful public discourse33. When they are, coverage often focuses on humour, discomfort, or ageing rather than the complex physiological and psychological changes that occur – reinforcing stigma rather than alleviating it34-37.
For women in leadership roles, turning to alcohol or medication for relief may conflict with professional expectations of composure and control38. Awareness of these challenges can be misinterpreted as instability, carrying potential reputational or organisational consequences39-43. Such misperceptions risk discouraging women from seeking early, compassionate intervention – right when it can be most effective44-45.
For these reasons, many women remain silent – often employing masking techniques to preserve an appearance of competence and control46-47. This may include concealing exhaustion, minimising symptoms, or normalising escalating substance use as a form of self-management.
The invisibility of substance dependencies for women in midlife could potentially give rise to entrenched patterns of coping that become progressively harder to interrupt. These dependencies can heighten vulnerability to anxiety and depression, and the secrecy surrounding them often fosters profound isolation – at precisely the stage of life when compassionate, whole-person support is most needed3, 10-11, 17.
The Long-Term Harm of Self-Medicating
Dependency on stimulants, sedatives or alcohol comes with significant health risks. Research suggests that the harmful effects of alcohol include liver damage, cardiovascular disease and certain types of cancer48. At the same time, long-term use of sedatives can impair memory and reduce cognitive function, therefore affecting the woman’s professional capacity49.
Repeated use of stimulants – including cocaine and amphetamine-type substances – is associated with worsening anxiety and fatigue50. Chronic stimulant exposure is linked to mood instability, impaired executive function, and increased psychiatric risk (e.g. amphetamine use has been associated with higher rates of anxiety, aggression, and cognitive decline in long-term use)51. Over time, such neurophysiological strain may erode mental stamina – weakening capacity for decisive strategic thinking under pressure, such as in boardroom deliberations.
The personal cost of prolonged substance use can be profound. An individual navigating substance use may become increasingly irritable or withdrawn, often accompanied by guilt, fatigue, or emotional dysregulation52-55.
This can strain marriages through broken trust and emotional distance56-59, disrupt children’s sense of stability60, and undermine professional networks by diminishing reliability, communication, or credibility61-63. In addition, self-medication can erode one’s sense of identity – gradually replacing clarity and confidence with exhaustion, shame, and symptoms of anxiety or depression64-68.
At Harbor, we support every dimension of recovery – emotional, psychological, physical, and spiritual – to restore lasting equilibrium and wellbeing.
Harbor London: Private Addiction and Menopause Treatment in London
From initial assessment to long-term aftercare, Harbor London provides fully integrated care shaped around the unique needs and preferences of each individual. Every hand-selected multidisciplinary team – comprised of world-leading specialists – works seamlessly to unite psychiatry, psychology, nutrition, and integrative wellness into an immersive and highly personalised care environment.
Each stage of the recovery journey is thoughtfully designed, planned with dignity, and delivered with absolute discretion. Within Harbor’s private, restorative spaces, clients are supported to rediscover a life they value – one grounded in balance, fulfilment, and sustainable wellbeing.
Our Women’s Health Programme, focused exclusively on one client at a time, may incorporate carefully calibrated techniques designed to restore equilibrium in both body and mind, including:
- Hormonal and medical support: Family doctors and women’s health specialists provide private addiction and menopause treatment in London, assessing the suitability of hormone replacement therapy (HRT) or non-hormonal alternatives to help regulate sleep, stabilise mood, and alleviate physiological symptoms.
- Psychological support: Addressing challenges surrounding anxiety, trauma, and identity with the deepest compassion, Harbor’s therapeutic teams may include psychologists, psychotherapists, and specialists in both addiction and menopause. Treatment approaches can integrate cognitive behavioural therapy (CBT), somatic therapies, EMDR, and hypnotherapy – all tailored to the individual.
- Whole-person wellness: Each client’s team also considers the broader context of wellbeing during menopause – encompassing nutrition, gentle movement, and restorative practices such as meditation or mindfulness.
Harbor’s philosophy – defined by care, compassion, and discretion – supports each woman in navigating her path toward recovery, resilience, and renewed wellbeing in both personal and professional life.
